These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12413668)

  • 1. Is sensorineural hearing loss a possible side effect of nasopharyngeal and parotid irradiation? A systematic review of the literature.
    Raaijmakers E; Engelen AM
    Radiother Oncol; 2002 Oct; 65(1):1-7. PubMed ID: 12413668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term sensorineural hearing deficit following radiotherapy in patients suffering from nasopharyngeal carcinoma: A prospective study.
    Ho WK; Wei WI; Kwong DL; Sham JS; Tai PT; Yuen AP; Au DK
    Head Neck; 1999 Sep; 21(6):547-53. PubMed ID: 10449671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective study of sensorineural hearing loss following radiotherapy for nasopharyngeal carcinoma.
    Li JJ; Guo YK; Tang QL; Li SS; Zhang XL; Wu PA; Yang XM
    J Laryngol Otol; 2010 Jan; 124(1):32-6. PubMed ID: 19840426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A long-term study on hearing status in patients with nasopharyngeal carcinoma after radiotherapy.
    Wang LF; Kuo WR; Ho KY; Lee KW; Lin CS
    Otol Neurotol; 2004 Mar; 25(2):168-73. PubMed ID: 15021778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective longitudinal study on radiation-induced hearing loss.
    Anteunis LJ; Wanders SL; Hendriks JJ; Langendijk JA; Manni JJ; de Jong JM
    Am J Surg; 1994 Nov; 168(5):408-11. PubMed ID: 7977961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.
    Honoré HB; Bentzen SM; Møller K; Grau C
    Radiother Oncol; 2002 Oct; 65(1):9-16. PubMed ID: 12413669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term hearing results and otological complications of nasopharyngeal carcinoma patients: comparison between treatment with conventional two-dimensional radiotherapy and intensity-modulated radiotherapy.
    Tsang RK; Kwong DL; Ho AC; To VS; Ho WK; Wei WI
    ORL J Otorhinolaryngol Relat Spec; 2012; 74(4):228-33. PubMed ID: 22907195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Otological toxicity after postoperative radiotherapy for parotid tumours.
    Bhide SA; Harrington KJ; Nutting CM
    Clin Oncol (R Coll Radiol); 2007 Feb; 19(1):77-82. PubMed ID: 17305258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation-induced hearing impairment in patients treated for malignant parotid tumor.
    Chen WC; Liao CT; Tsai HC; Yeh JY; Wang CC; Tang SG; Hong JH
    Ann Otol Rhinol Laryngol; 1999 Dec; 108(12):1159-64. PubMed ID: 10605921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Late effects of radiotherapy on hearing.
    Schot LJ; Hilgers FJ; Keus RB; Schouwenburg PF; Dreschler WA
    Eur Arch Otorhinolaryngol; 1992; 249(6):305-8. PubMed ID: 1418938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensori-neural hearing loss in patients treated with irradiation for nasopharyngeal carcinoma.
    Grau C; Møller K; Overgaard M; Overgaard J; Elbrønd O
    Int J Radiat Oncol Biol Phys; 1991 Aug; 21(3):723-8. PubMed ID: 1869465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analyses of sudden sensorineural hearing loss in 14 nasopharyngeal carcinomas following radiotherapy].
    Chen P; Tang AZ; Zhang Z; Yin SH; Cai HW; Fang Q; He GY
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Sep; 46(9):705-8. PubMed ID: 22177034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
    Kwong DL; Wei WI; Sham JS; Ho WK; Yuen PW; Chua DT; Au DK; Wu PM; Choy DT
    Int J Radiat Oncol Biol Phys; 1996 Sep; 36(2):281-9. PubMed ID: 8892450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y; Zhou T; Zhu J; Zhang Y; Sun M; Ding X; Wang D; Li H; Li B
    Cell Biochem Biophys; 2014 Jul; 69(3):433-7. PubMed ID: 24510513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hearing disability before and after radiotherapy for nasopharyngeal carcinoma.
    Low WK; Fong KW
    J Laryngol Otol; 1996 Feb; 110(2):121-3. PubMed ID: 8729492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC; Jackson A; Budnick AS; Pfister DG; Kraus DH; Hunt MA; Stambuk H; Levegrun S; Wolden SL
    Cancer; 2006 Feb; 106(4):820-9. PubMed ID: 16421885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH; Ng WT; Kam KL; Lee MC; Choi CW; Yau TK; Lee AW; Chow SK
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1335-42. PubMed ID: 18922648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
    Low WK; Toh ST; Wee J; Fook-Chong SM; Wang DY
    J Clin Oncol; 2006 Apr; 24(12):1904-9. PubMed ID: 16622266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term hearing status after radiotherapy for nasopharyngeal carcinoma.
    Low WK; Fong KW
    Auris Nasus Larynx; 1998 Jan; 25(1):21-4. PubMed ID: 9512790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylprednisolone use during radiotherapy extenuates hearing loss in patients with nasopharyngeal carcinoma.
    Chen J; Zhao Y; Zhou X; Tan L; Ou Z; Yu Y; Wang Y
    Laryngoscope; 2016 Jan; 126(1):100-3. PubMed ID: 26309227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.